Anogenital cancers testing in Rieti

Find health labs to test for Anogenital cancers in Rieti and compare all offers by prices and services.

Tests that cover Anogenital cancers

HPV Test
Pap Smear by Synlab

Largo F. Spadoni, 4, 02100 Rieti RI, Italia

Unverified

See Details

test HPV cavo orale autoprelievo by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Test by innovabiohealth S.r.l.

Test at-Home / Self-testing

Featured

€65.00

€61.75 with our promocode

See Details

Pap Smear by Synlab

Località Scalette, 02038 Scandriglia RI, Italia

16.6 km

Unverified

See Details

Pap Test by Salvati Diagnostica - Poliambulatorio e Laboratorio Analisi

Piazza del Mercato, 61, 05100 Terni TR, Italia

15.4 km

Unverified

See Details

Pap Test by Salvati Diagnostica - Poliambulatorio e Laboratorio Analisi

Via Tuderte, 426, 05035 Narni TR, Italia

19.4 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Bachelet, 32 00065 Fiano Romano (RM)

21.2 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Giuseppe Di Vittorio, 3 00067 Morlupo (Roma)

25.7 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Tiburtina Valeria, 36 00029 Vicovaro (RM)

27 km

Unverified

See Details

Pap Smear by Synlab

Via Edmondo Riva, 59, 00015 Monterotondo RM, Italia

27.5 km

Unverified

See Details

Pap Test by Synlab

Via Edmondo Riva, 59, 00015 Monterotondo RM, Italia

27.5 km

Unverified

See Details

Pap Smear by Laboratorio Analisi Cliniche Europa

Viale Duca degli Abruzzi, 67, 67100 L'Aquila AQ, Italia

27.6 km

Unverified

See Details

Pap Smear by Laboratorio Lifebrain

Via Salaria, 164 00015 Monterotondo (RM)

27.5 km

Unverified

See Details

Anogenital cancers - symptoms and how to test

Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.